Logo

Incyte Plans Private Placement of $150M in Convertible Notes

Feb 11, 2004

NEW YORK, Feb. 11 (GenomeWeb News) - Incyte today said it intends to offer a private placement of $150 million in convertible subordinated notes due in 2011.

 

The interest-bearing notes will be converted into shares of Incyte common stock at a rate and a price to be determined. The company said it expects to also grant initial purchasers of the notes an option to purchase up to an additional $50 million aggregate principal amount of the notes.

 

The company will use the net proceeds of the offering for general purposes, including the repayment of outstanding debt.

 

Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.